Literature DB >> 9848124

A model for pharmacokinetics and physiological feedback among hormones of the testicular-pituitary axis in adult male rats: a framework for evaluating effects of endocrine active compounds.

H A Barton1, M E Andersen.   

Abstract

The testicular-hypothalamic-pituitary axis controls reproductive functions in males. A description of the basic physiological interactions in adult rats among testosterone, luteinizing hormone (LH), and follicle stimulating hormone (FSH) was developed, permitting simulation of hormone levels in testes and blood. This model was used to simulate hormone levels in intact, castrate, ethane dimethanesulfonate-treated, and antiandrogen-treated rats. A large gradient of testosterone concentrations from testicular interstitial fluid to low levels in peripheral blood is created by the testicular blood flow. The dominant feedback loop is positive regulation of testosterone synthesis by LH and negative feedback of testosterone on LH and FSH. The utility of the model for placing in vitro data in the context of in vivo physiology was illustrated for the case of continued synthesis of testosterone by the isolated testes. In the absence of blood flow, very low residual testosterone synthesis can substantially increase testosterone concentration in isolated testes. Effects of an exogenous endocrine active compound were illustrated by modeling altered LH and FSH regulation by testosterone in the presence of an antiandrogen acting as a competitive ligand for the androgen receptor. Increasing concentrations have no effect on steady-state hormone levels until sufficient levels of antiandrogen are achieved to reduce negative feedback of testosterone on LH and FSH. In summary, a model has been developed that provides a basis for initiating evaluations of key issues of concern for the risk assessment of endocrine active compounds including in vitro to in vivo extrapolation and their dose-response behaviors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848124     DOI: 10.1006/toxs.1998.2538

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  5 in total

1.  Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analogues.

Authors:  Christoffer W Tornøe; Henrik Agersø; Thomas Senderovitz; Henrik A Nielsen; Henrik Madsen; Mats O Karlsson; E Niclas Jonsson
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

2.  Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer.

Authors:  Trevor Reckell; Kyle Nguyen; Tin Phan; Sharon Crook; Eric J Kostelich; Yang Kuang
Journal:  J Theor Biol       Date:  2021-01-07       Impact factor: 2.691

3.  A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.

Authors:  Michael G Zager; Hugh A Barton
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

4.  A computational model of the hypothalamic: pituitary: gonadal axis in female fathead minnows (Pimephales promelas) exposed to 17α-ethynylestradiol and 17β-trenbolone.

Authors:  Zhenhong Li; Kevin J Kroll; Kathleen M Jensen; Daniel L Villeneuve; Gerald T Ankley; Jayne V Brian; María S Sepúlveda; Edward F Orlando; James M Lazorchak; Mitchell Kostich; Brandon Armstrong; Nancy D Denslow; Karen H Watanabe
Journal:  BMC Syst Biol       Date:  2011-05-05

5.  Quantitative mechanistically based dose-response modeling with endocrine-active compounds.

Authors:  M E Andersen; R B Conolly; E M Faustman; R J Kavlock; C J Portier; D M Sheehan; P J Wier; L Ziese
Journal:  Environ Health Perspect       Date:  1999-08       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.